Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
292.35
-1.76 (-0.60%)
Mar 24, 2026, 10:14 AM EDT - Market open

PRAX Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-303.27-182.82-123.28-214.03-167.06
Depreciation & Amortization
0.140.360.430.420.18
Stock-Based Compensation
33.9441.3624.8628.5922.69
Other Adjustments
-2.56-1.580.881.813.46
Changes in Accounts Payable
12.16.71-8.863.897.27
Changes in Accrued Expenses
11.216.11-8.5-10.4715.45
Changes in Unearned Revenue
--2.55-2.455-
Changes in Other Operating Activities
-0.62-9.355.77-0.26-6.54
Operating Cash Flow
-249.07-131.76-111.14-185.04-124.55
Capital Expenditures
-0.06--0.05-0.44-1.05
Purchases of Investments
-623.81-371.52--83.02-164.17
Proceeds from Sale of Investments
312.72123.0339180.3624.7
Investing Cash Flow
-311.15-248.4938.9596.89-140.52
Issuance of Common Stock
704.26514.6392.0110.99108.16
Repurchase of Common Stock
-2.09-0.31-0.14-0.26-
Net Common Stock Issued (Repurchased)
702.17514.3291.8710.73108.16
Other Financing Activities
----0.26-0.58
Financing Cash Flow
702.17514.3291.8710.47107.59
Net Cash Flow
141.96134.0719.69-77.69-157.49
Free Cash Flow
-249.12-131.76-111.19-185.49-125.6
FCF Margin
--1540.48%-4543.77%--
Free Cash Flow Per Share
-11.07-7.36-16.86-60.36-44.38
Levered Free Cash Flow
-280.51-171.54-136.93-215.89-151.76
Unlevered Free Cash Flow
-303.44-188.89-140.02-216.85-152.03
Updated Feb 19, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q